CONBRIZA

Страна: Израиль

Язык: английский

Источник: Ministry of Health

Активный ингредиент:

BAZEDOXIFENE AS ACETATE 20 MG

Доступна с:

NEOPHARM LTD

код АТС:

G03XC02

Фармацевтическая форма:

COATED TABLETS

Администрация маршрут:

PER OS

Производитель:

PFIZER IRELAND PHARMACEUTICALS

Терапевтическая группа:

BAZEDOXIFENE

Терапевтические показания :

CONBRIZA is indicated for the treatment of postmenopausal osteoporosis in women at increased risk of fracture. A significant reduction in the incidence of vertebral fractures has been demonstrated; efficacy on hip fractures has not been established. When determining the choice of CONBRIZA or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefit

Дата Авторизация:

2013-04-01